Meridian Bioscience Receives FDA Clearance For New Rapid Campylobacter Test (Medical News Today)
Meridian Bioscience, Inc. (NASDAQ: VIVO) announced that it has received FDA clearance from the U.S. Food and Drug Administration (FDA) for a new rapid test for Campylobacter, ImmunoCard STAT! CAMPY.

Corrupted asthma drug trials spotlight FDA s hasty approvals (Online Journal)
A major allergy and respiratory management company knowingly produced flawed clinical trials of FDA approved drugs currently on the market, a Texas physician has charged.

InSite Vision Announces FDA Approval Of New Ophthalmic Product Enabled By InSite's DuraSite Technology (Medical News Today)
InSite Vision Incorporated (OTCBB:INSV) announced that Bausch & Lomb has received approval of Besivance (besifloxacin ophthalmic suspension) 0.6% for the treatment of bacterial conjunctivitis ("pink eye") in patients one year and older from the U.S. Food and Drug Administration (FDA).